Role of collectins in innate immunity against aspergillosis

References

• Schaffner T, Keller HU, Hess MW, Cottier H. Macrophage functions in antimicrobial defense. Klin Wochenschr 1982; 60: 720–726
   Google Scholar
• Dixon DM, Polak A, Conner GW. Mel- mutants of Wangiella dermatitidis in mice: evaluation of multiple mouse and fungal strains. J Med Vet Mycol 1989; 27: 335–341
   PubMedGoogle Scholar
• Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 6: 4870–4877
   Google Scholar
• Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547–578
   PubMed Web of Science ®Google Scholar
• Lu J, Teh C, Kishore U, Reid KB. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 2002; 1572: 387–400
   PubMed Web of Science ®Google Scholar
• Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77: 931–962
   PubMed Web of Science ®Google Scholar
• Madan T, Eggleton P, Kishore U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65: 3171–3179
   PubMed Web of Science ®Google Scholar
• Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982; 156: 430–442
   PubMed Web of Science ®Google Scholar
• Vorup-Jensen T, Sorensen ES, Jensen UB, et al. Recombinant expression of human mannan-binding lectin. Int Immunopharmacol 2001; 1: 677–687
   Google Scholar
• Madan T, Kishore U, Singh M, et al. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 2001; 107: 467–475
   PubMed Web of Science ®Google Scholar
• Madan T, Kishore U, Singh M, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001; 69: 2728–2731
   PubMed Web of Science ®Google Scholar
• Li G, Siddiqui J, Hendry M, et al. Surfactant protein A-deficient mice display an exaggerated early inflammatory response to a β-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002; 26: 277–282
   PubMed Web of Science ®Google Scholar
• Jain D, Dodia C, Bates SR, et al. SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues. Am J Physiol Lung Cell Mol Physiol 2003; 284: L759–L765
   Google Scholar
• Botas C, Poulain F, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998; 29: 11869–11874
   Google Scholar
• Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111: 1001–1007
   PubMed Web of Science ®Google Scholar
• van de Wetering JK, van Golde LM, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem 2004; 1: 1229–1249
   Google Scholar
• Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 176: 1497–1502
   PubMed Web of Science ®Google Scholar
• Hickling TP, Bright H, Wing K, et al. Recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol 1999; 29: 3478–3484
   PubMed Web of Science ®Google Scholar
• Jensenius JC, Jensen PH, McGuire K, Larsen JL, Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003; 31: 763–767
   PubMedGoogle Scholar
• Homer RJ, Zheng T, Chupp G, et al. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 2002; 283: L52–L59
   Google Scholar
• Lee JJ, McGarry MP, Farmer SC, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185: 2143–2156
   PubMed Web of Science ®Google Scholar
• Schmid-Grendelmeier P, Altznauer F, Fischer B, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002; 169: 1021–1027
   PubMed Web of Science ®Google Scholar
• Hawgood S, Ochs M, Jung A, et al. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1002–L1010
   PubMed Web of Science ®Google Scholar